These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1563532)

  • 21. Timing between the subcutaneous administration of insulin and consumption of a carbohydrate rich meal.
    Heinemann L; Starke AA; Hohmann A; Berger M
    Horm Metab Res Suppl; 1992; 26():137-9. PubMed ID: 1490682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed onset of action of soluble insulin after premixing with U100 lente insulin.
    Heine RJ; Sikkenk AC; Eizenga WH; van der Veen EA
    Diabetes Res Clin Pract; 1986; 2(6):353-8. PubMed ID: 3545725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Venous versus arterialised venous blood for assessment of blood glucose levels during glucose clamping: comparison in healthy men.
    Wahab PJ; Rijnsburger AW; Oolbekkink M; Heine RJ
    Horm Metab Res; 1992 Dec; 24(12):576-9. PubMed ID: 1478616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and biological activity of the new intermediate-acting insulin L-SNC).
    Schulz B; Menzel R; Ratzmann KP; Heinke P
    Exp Clin Endocrinol; 1987 Dec; 90(3):278-84. PubMed ID: 3330036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PROMAXX inhaled insulin: safe and efficacious administration with a commercially available dry powder inhaler.
    Heise T; Brugger A; Cook C; Eckers U; Hutchcraft A; Nosek L; Rave K; Troeger J; Valaitis P; White S; Heinemann L
    Diabetes Obes Metab; 2009 May; 11(5):455-9. PubMed ID: 19236443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of potency of porcine insulin and semisynthetic human insulin at 3 dose levels using the euglycaemic clamp.
    Chisholm DJ; Kraegen EW; Hewett MJ; Lazarus L
    Horm Metab Res; 1983 Sep; 15(9):415-8. PubMed ID: 6357983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioactivity and pharmacokinetics of human proinsulin in comparison to human insulin after intravenous and subcutaneous injection.
    Schatz H; Ammermann S; Laube H; Federlin K
    Horm Metab Res; 1988 Jul; 20(7):445-9. PubMed ID: 3049293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin.
    Howey DC; Bowsher RR; Brunelle RL; Woodworth JR
    Diabetes; 1994 Mar; 43(3):396-402. PubMed ID: 8314011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Action profiles of fast onset insulin analogues.
    Heinemann L; Starke AA; Heding L; Jensen I; Berger M
    Diabetologia; 1990 Jun; 33(6):384-6. PubMed ID: 2199281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer.
    Heinemann L; Klappoth W; Rave K; Hompesch B; Linkeschowa R; Heise T
    Diabetes Care; 2000 Sep; 23(9):1343-7. PubMed ID: 10977030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Action profile of the rapid acting insulin analogue: human insulin B28Asp.
    Heinemann L; Heise T; Jorgensen LN; Starke AA
    Diabet Med; 1993 Jul; 10(6):535-9. PubMed ID: 8365089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Porcine and human insulin absorption from subcutaneous tissues in normal and insulin-dependent diabetic subjects: a deconvolution-based approach.
    Nosadini R; De Kreutzenberg S; Duner E; Iori E; Avogaro A; Trevisan R; Fioretto P; Doria A; Merkel C; Cobelli C
    J Clin Endocrinol Metab; 1988 Sep; 67(3):551-9. PubMed ID: 3045144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The absorption of subcutaneously injected short-acting soluble insulin: influence of injection technique and concentration.
    Hildebrandt P; Sestoft L; Nielsen SL
    Diabetes Care; 1983; 6(5):459-62. PubMed ID: 6400706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of storage temperature of insulin on pharmacokinetics and pharmacodynamics of insulin mixtures injected subcutaneously in subjects with type 1 (insulin-dependent) diabetes mellitus.
    Perriello G; Torlone E; Di Santo S; Fanelli C; De Feo P; Santeusanio F; Brunetti P; Bolli GB
    Diabetologia; 1988 Nov; 31(11):811-5. PubMed ID: 3069528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of insulin analogue B9AspB27Glu and soluble human insulin in insulin-treated diabetes.
    Kang S; Owens DR; Vora JP; Brange J
    Lancet; 1990 Feb; 335(8685):303-6. PubMed ID: 1967767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absorption kinetics and action profiles of subcutaneously administered insulin analogues (AspB9GluB27, AspB10, AspB28) in healthy subjects.
    Kang S; Brange J; Burch A; Vølund A; Owens DR
    Diabetes Care; 1991 Nov; 14(11):1057-65. PubMed ID: 1797487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The action profiles of human NPH insulin preparations.
    Starke AA; Heinemann L; Hohmann A; Berger M
    Diabet Med; 1989 Apr; 6(3):239-44. PubMed ID: 2523785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of concentration on the kinetics of SC-infused insulin. Comparison between square-wave SC infusion and bolus SC injection.
    Murat A; Slama G
    Metabolism; 1985 Feb; 34(2):120-3. PubMed ID: 3881645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of mixing regular- and intermediate-acting insulins on their absorption and biological activity.
    Schulz B; Menzel R; Besch W
    Exp Clin Endocrinol; 1988 Mar; 91(1):27-34. PubMed ID: 3286272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble and Lente human insulin mixtures in normal man.
    Owens DR; Vora JP; Jones IR; Birtwell J; Atiea J; Luzio S; Williams S
    Diabetes Res; 1988 Jan; 7(1):35-40. PubMed ID: 3042252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.